Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression

Por Fierz, Yvonne, Novosyadlyy, Ruslan, Vijayakumar, Archana, Yakar, Shoshana, LeRoith, Derek
Publicado em 2010

mTOR Inhibition Abrogates Insulin-Mediated Mammary Tumor Progression in Type 2 Diabetes

Por Fierz, Yvonne, Novosyadlyy, Ruslan, Vijayakumar, Archana, Yakar, Shoshana, LeRoith, Derek
Publicado em 2010

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia

Por Gallagher, Emily Jane, Fierz, Yvonne, Vijayakumar, Archana, Haddad, Nadine, Yakar, Shoshana, LeRoith, Derek
Publicado em 2011

Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes

Por Ferguson, Rosalyn D, Novosyadlyy, Ruslan, Fierz, Yvonne, Alikhani, Nyosha, Sun, Hui, Yakar, Shoshana, LeRoith, Derek
Publicado em 2012

Insulin-mediated acceleration of breast cancer development and progression in a non-obese model of type 2 diabetes

Por Novosyadlyy, Ruslan, Lann, Danielle E., Vijayakumar, Archana, Rowzee, Anne, Lazzarino, Deborah A., Fierz, Yvonne, Carboni, Joan M., Gottardis, Marco M., Pennisi, Patricia A., Molinolo, Alfredo A., Kurshan, Naamit, Mejia, Wilson, Santopietro, Stefania, Yakar, Shoshana, Wood, Teresa L., LeRoith, Derek
Publicado em 2010